06:45 AM EST, 11/12/2026 (MT Newswires) -- Gulf Pharmaceutical Industries (ADX:JULPHAR), d/b/a Julphar, logged 32.9 million Emirati dirhams in profit attributable to equity holders of the parent for the third quarter, compared with 6.3 million dirhams a year ago. EPS moved to 0.0285 dirham from 0.0055 dirham year over year, a Thursday filing showed. For the three months ended Sept. 30, revenue from contracts with customers was 332.3 million dirhams versus 250 million dirhams previously, the United Arab Emirates-listed pharmaceutical manufacturer added.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.